What SIRO Clinpharm does

SIRO Clinpharm Private Limited is a Mumbai-headquartered clinical research organization (CRO) founded in 1996 as the SIRO Research Foundation and incorporated in 2000. The company delivers drug development and discovery solutions to global pharmaceutical, biotechnology, medical device, and academic institutions, operating through three wholly-owned specialized verticals: SIRO Clintech (full-service CRO offering study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management), SIRO Medical Writing (regulatory filings, safety reports, scientific publications), and SIRO Functional Services (FSP workforce solutions).

The company's core offering is its Functional Service Provider (FSP) model, which provides flexible workforce augmentation through staff augmentation, managed staffing, and hybrid engagement models, with FTE-based pricing. SIRO operates a suite of web-based clinical trial applications including EDC (Electronic Data Capture), CTMS (Clinical Trial Management System), IWRS (Interactive Web Response System), and e-Diary for patient-reported outcomes. Through a strategic partner network, SIRO maintains the ability to hire and employ resources across 150+ countries, addressing multinational trial staffing and local regulatory compliance requirements for global sponsors.

SIRO is founder-controlled, with Akshay Daftary and Karan Daftary serving as Managing Directors and Gautam Daftary as Chairman. The company raised approximately $30.5M across two PE rounds in 2006-2007 from Baring Private Equity India, 3i Group, and Kotak Private Equity. It has 251-500 employees and recently secured SBTi approval for 42% Scope 1/2 emissions reduction by 2030. The GTM motion is direct enterprise sales via RFI/RFP processes targeting large multinational sponsors.

Name

SIRO Clinpharm

Legal name

SIRO Clinpharm Private Limited

Website

https://siroclinpharm.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

251–500 employees

Short description

SIRO Clinpharm is a Mumbai-based CRO offering FSP workforce solutions and full-service clinical development across three specialized verticals, serving global pharma, biotech, medical device, and academic clients in 150+ countries.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Functional Service Providers (FSP) & Resourcing CROs (HLAGAAAM), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG)

Keywords

• Contract research organization
• Clinical research services
• Functional service provider
• Medical writing services
• Pharmacovigilance services

Headquarters

HQ city

Thane

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Functional Service Provider (FSP) Solutions: SIRO provides flexible FSP solutions allowing clients to augment their teams with specialized resources for clinical trial functions. Services include staff augmentation (FTE-based model), managed staffing, and hybrid models. Revenue is generated through FTE (full-time equivalent) based pricing models with flexible deployment options.
2. Full-Service CRO Services (SIRO Clintech): Through its subsidiary SIRO Clintech, the company offers full-service clinical development services including study design, site management, data management, biostatistics, medical writing, and clinical trial supplies management.
3. Medical Writing Services (SIRO Medical Writing): Best-in-class medical writing services supporting drug development from regulatory filings and safety reports to scientific publications, delivered through the specialized SIRO Medical Writing subsidiary.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

SIRO Clinpharm is a Contract Research Organization (CRO) that delivers clinical research and drug development solutions through three specialized verticals: SIRO Clinpharm's Functional Service Provider (FSP) solutions (staff augmentation, managed staffing, and hybrid models), SIRO Clintech's full-service clinical development offerings (study design, site management, data management, biostatistics, and clinical trial supplies), and SIRO Medical Writing's regulatory and scientific documentation services.

Product overview

SIRO Clinpharm is a Contract Research Organization (CRO) offering a multi-product portfolio organized into three specialized vertical companies under the SIRO Group umbrella. The core offering is SIRO Clinpharm's Functional Service Provider (FSP) services, which deliver flexible workforce solutions for clinical trial operations including staff augmentation, managed staffing, and hybrid engagement models with global reach across 150+ countries. This is complemented by SIRO Clintech, a full-service CRO providing end-to-end clinical development services from study design through data management and biostatistics. SIRO Medical Writing provides specialized regulatory and scientific documentation services. Together, these three verticals serve global biotech, pharmaceutical, medical device, and academic institutions across the drug development lifecycle.

Differentiator

Problem solved

Functional benefit

Products and services

• SIRO Clinpharm FSP Services Functional Service Provider (FSP) solutions providing flexible workforce augmentation for clinical trial functions. Includes staff augmentation (FTE-based, on-site or remote resources under client supervision), FSP managed staffing (SIRO provides functional oversight, hiring and line management), and hybrid models combining FTE and FSO approaches. Enables global deployment across 150+ countries with quick resource scaling.
• SIRO Clintech Full-Service CRO Full-service Contract Research Organization offering a complete spectrum of clinical development services including study design, site management, clinical monitoring, data management, biostatistics and statistical programming, medical writing, and clinical trial supplies management. Delivered by wholly-owned subsidiary SIRO Clintech Private Limited for global pharma, biotech, medical device and academic clients.
• SIRO Medical Writing Medical writing services supporting drug development from initial regulatory filings and safety reports to impactful scientific publications. Expertise spans the entire value chain of clinical documentation. Delivered by wholly-owned subsidiary SIRO Medical Writing Private Limited.

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Strategic Partner NetworkcoreOthersSIRO collaborates with strategic partners to provide resources in 150+ countries where clients may not have representation or where local regulatory compliance is difficult. The partnership enables SIRO to hire and employ across 150+ countries, extending global reach for clinical trial operations.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• IQVIA: IQVIA is the world's largest CRO and life sciences services firm, offering full-service clinical development, FSP/resourcing, and technology platforms (EDC, CTMS). It competes with SIRO on enterprise pharma RFPs and FSP engagements globally, but at vastly greater scale.
• ICON plc: ICON is a top-tier global CRO offering full-service clinical development, FSP via ICON Functional Services, and biostatistics/data management. It is the most direct large incumbent comparable to SIRO's combined full-service CRO + FSP + biostatistics offering.
• Labcorp Drug Development (Fortrea): Fortrea, spun out from Labcorp, is a global CRO providing clinical development, FSP/resourcing, and central lab services. Comparable to SIRO's full-service CRO and FSP verticals, with much larger geographic reach and central lab capabilities SIRO lacks.
• Parexel International: Parexel is a global CRO (now private-equity owned by EQT/Goldman) offering full-service clinical development, biostatistics, regulatory, and FSP solutions. Comparable across the same service lines as SIRO's three verticals, though at significantly larger scale and global footprint.
• Syneos Health: Syneos Health is a global clinical and commercial solutions provider offering full-service CRO, FSP, biostatistics, and medical writing. Direct overlap with SIRO's portfolio across all three verticals; recently taken private by Elliott/Veritas, indicating a comparable roll-up trajectory.
• Charles River Laboratories: Charles River is a global CRO/CDMO with clinical development services, FSP, and safety/pharmacovigilance offerings. Comparable to SIRO across CRO and FSP, with additional discovery/manufacturing capabilities and global lab footprint.

Direct peers

• Medpace Holdings: Medpace is a mid-to-large global CRO focused on full-service clinical development across multiple therapeutic areas. Comparable to SIRO Clintech's full-service CRO offering, though Medpace operates at significantly larger scale with proprietary technology and a US-centric delivery model.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO offering full-service clinical development, biostatistics, data management, and medical writing. Closely comparable to SIRO in scale and service mix, especially the SIRO Clintech and SIRO Medical Writing verticals.
• Novotech: Novotech is an Asia-Pacific-focused mid-sized CRO offering full-service clinical development with strong India and regional delivery. Highly comparable to SIRO in geographic positioning, India-based delivery, and mid-tier CRO scale.

Emerging players

• CliniOps: CliniOps is a digital clinical trials platform and FSP provider with India-based operations, focused on decentralized trials and clinical data services. Comparable to SIRO's FSP and data management capabilities, with a more technology-forward positioning.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/in/akshay-daftary-a5733361
• Xx.com/siroclinpharm

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SIRO Clinpharm